Compare Davita Inc (DVA) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Zoom Video Communications, Inc. — how do they compare? Davita Inc trades at $230.44 (market cap $14.92B), while Zoom Video Communications, Inc. trades at $91.68 (market cap $26.73B). The key difference: Zoom Video Communications, Inc. is the larger of the two by market cap, and Davita Inc is trading nearer its 52-week high, Zoom Video Communications, Inc. nearer its low. Which is the better fit depends on your goals.
| DVA | ZM | |
|---|---|---|
Market Cap | $14.92B | $26.73B |
Sector | Health | Technology |
52-Week High | $235.71 | $111.88 |
52-Week Low | $103.87 | $69.77 |
Enterprise Value | $27.47B | $19.07B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
Zoom Communications (ZM) trades at $91.88, up 2.36% on the day, with a bullish technical signal from moving averages and a neutral RSI. The stock shows strong profitability with a net income margin of 41.99% and a P/E ratio of 13.53, trading below the analyst consensus price target of $118.79. Recent developments include the acquisition of Common Room and expansion of AI-powered Zoom Virtual Agent capabilities, signaling growth initiatives.
The outlook for ZM is positive, supported by robust cash flow, AI integration, and an undervalued stake in Anthropic ahead of its IPO. Risks include competitive pressure from Microsoft and Google, insider selling, and fluctuating cash flow trends. Wall Street sentiment is mixed, with 39% of analysts rating it a buy, but the stock offers value if execution on AI-driven growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
